tiprankstipranks

Jason Gross Insider Profile

4 Followers
Jason Gross, Vice-President at HLS Therapeutics Inc, holds 49.70K shares in HLS Therapeutics Inc (Ticker: TSE:HLS), holds 42.50K shares in Cipher Pharmaceuticals (Ticker: CPHRF). Most recently, Jason Gross Bought ― shares of HLS Therapeutics Inc on Dec 10, 2019 for an estimated value of 3.51K.
tipranks
Jason Gross

Jason Gross
HLS Therapeutics Inc (HLS)
Vice-President

Not Ranked
Jason Gross has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$418K
58.69%
41.31%
A breakdown of Jason Gross's holdings

Insider Roles

Cipher Pharmaceuticals
(CPHRF)
Divisional Vice-President
HLS Therapeutics Inc
(HLS)
Vice-President
Roles that Jason Gross holds in companies

Most Profitable Insider Trade

Stock:
HLS Therapeutics Inc
(HLS)
Rating:Informative Buy
Date:Dec 10, 2019 - Dec 10, 2020
Return:-2.90%
The most profitable trade made by Jason Gross

Jason Gross's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HLS Therapeutics Inc
Dec 10, 2019
Vice-President
Informative Buy
3.51K
C$193.83K
Cipher Pharmaceuticals
Nov 11, 2013
Divisional Vice-President
Informative Sell
221.38K
$275.36K
List of latest transactions for each holding click on a transaction to see Jason Gross's performance on stock

Jason Gross insider profile FAQ

What is the percentage of profitable transactions made by Jason Gross?
The percentage of profitable transactions made by Jason Gross is ―.
    What is the average return per transaction made by Jason Gross?
    The average return per transaction made by Jason Gross is ―.
      What stocks does Jason Gross hold?
      Jason Gross holds: TSE:HLS, CPHRF stocks.
        What was Jason Gross’s latest transaction?
        Jason Gross latest transaction was an Informative Buy of C$3.51K.
          What was Jason Gross's most profitable transaction?
          Jason Gross’s most profitable transaction was an Informative Buy of TSE:HLS stock on December 10, 2019. The return on the trade was -2.90%.
            What is Jason Gross's role in HLS Therapeutics Inc?
            Jason Gross's role in HLS Therapeutics Inc is Vice-President.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.